NCT01880983View on ClinicalTrials.gov

Mitoferrin-1 Expression in Erythropoietic Protoporphyria (Porphyria Rare Disease Clinical Research Consortium (RDCRC))

CompletedOBSERVATIONAL
Enrollment

150

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

December 31, 2020

Study Completion Date

December 31, 2020

Conditions
Erythropoietic Protoporphyria (EPP)
Trial Locations (1)

35294

The University of Alabama at Birmingham, Birmingham

All Listed Sponsors
collaborator

Porphyria Rare Disease Clinical Research Consortium

UNKNOWN

lead

University of Alabama at Birmingham

OTHER

NCT01880983 - Mitoferrin-1 Expression in Erythropoietic Protoporphyria (Porphyria Rare Disease Clinical Research Consortium (RDCRC)) | Biotech Hunter | Biotech Hunter